Wojciech R. Dolliver, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA
Alejandro A. Diaz, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA
Chest computed tomography (CT) imaging is a useful tool that provides in vivo information regarding lung structure. Imaging has contributed to a better understanding of chronic obstructive pulmonary disease (COPD), allowing for the detection of early structural changes and the quantification of extra-pulmonary structures. Novel CT imaging techniques have provided insight into the progression of the main COPD subtypes, such as emphysema and small airway disease. This article serves as a review of new information relevant to COPD imaging.
CT abnormalities, such as emphysema and loss of airways, are present even in smokers who do not meet the criteria for COPD and in those with mild-to-moderate disease. Subjects with mild-to-moderate COPD, with the highest loss of airways, also experience the highest decline in lung function. Extra-pulmonary manifestations of COPD, such as right ventricle enlargement and low muscle mass measured on CT, are associated with increased risk for all-cause mortality.
CT longitudinal data has also given insight into the progression of COPD. Mechanically affected areas of lung parenchyma adjacent to emphysematous areas are associated with a greater decline in forced expiratory volume in one second (FEV1). Subjects with the greatest percentage of small airway disease, as measured on matched inspiratory-expiratory CT scan, also present with the greatest decline in lung function.
Keywords: Chest computed tomography. Chronic obstructive pulmonary disease. Emphysema. Muscle mass. Small airway disease.
